Biovac OCV-S
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Biovac OCV-S, covering 2026-01-12 to 2026-01-12. Get the full timeline:
Most recent: Clinical Trial Update: Trial to Evaluate Immunogenicity Non-Inferiority, Safety and Lot-to-Lot Consistency of Biovac OCV-S to Euvichol®-Plus [Phase 3]